Trials / Completed
CompletedNCT04431141
Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
A Randomized, Open-label, Multiple-dose, Cross-over Dosing Study to Evaluate Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Handok Inc. · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is to evaluate pharmacokinetic drug interaction between teneligliptin and empagliflozin in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teneligliptin | Teneligliptin alone |
| DRUG | Empagliflozin | Empagliflozin alone |
| DRUG | Teneligliptin and Empagliflozin | Teneligliptin and empagliflozin |
Timeline
- Start date
- 2020-09-15
- Primary completion
- 2020-11-16
- Completion
- 2021-01-25
- First posted
- 2020-06-16
- Last updated
- 2021-11-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04431141. Inclusion in this directory is not an endorsement.